Submit your image related to Pathways to be featured!

Get Social

Submit your Twitter account related to Organ Development to be featured!


Submit your blog on Organ Development to be featured!


Submit your event on Organ Development to be featured!


Submit your video on Organ Development to be featured!


Submit your charity on Organ Development to be featured!

Organ Development Pathway Bioinformatics

Disease and disorder research has been conducted in relation to the Organ Development Pathway and Neoplasms, Malignant Neoplasms, Cell Transformation, Neoplastic, Tissue Adhesions, Nervousness. The study of the Organ Development Pathway has been mentioned in research publications which can be found using our bioinformatics tool below. The Organ Development Pathway has been researched in relation to Cell Proliferation, Sensory Organ Development, Floral Organ Development, Cell Differentiation, Regeneration. The Organ Development Pathway complements our catalog of research reagents including antibodies and ELISA kits against NOTCH, WNT, AKR1B1, AR, BMP4.

Organ Development Bioinformatics Tool

Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Organ Development below! For more information on how to use Laverne, please read the How to Guide.
Vizit™, under license from BioVista Inc.

Top Research Reagents

We have 2972 products for the study of the Organ Development Pathway that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.

Other Calcium Channel Flower Homolog Recombinant Protein

Species Human
Applications WB, ELISA, PA

Western blot shows lysates of A431 human epithelial carcinoma cell line and HeLa  human cervical epithelial carcinoma cell line untreated (-) or treated (+) with 100 ng/mL Recombinant Human EGF (Catalog # <a class=  EGF R/ErbB1phosphorylated at Y1086  was detected in immersion fixed A431 human epithelial carcinoma cell line  treated with Recombinant Human EGF (Catalog #<br><a class=

Species Human
Applications WB, Simple Western, ICC

Western Blot: Androgen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) [NB100-56603] -  LNCaP cells (passage number 38) were serum-starved for 2 days.  After serum starvation, cells were (A) left untreated, (B) treated with 100 ng/ml IGF-1 for 4h, or (C) incubated with 20 um LY294002 for 30 min prior to treatment with 100 ng/ml IGF-1 for 4 h. (See Lin, H-K., Y-C Hu, L. Yang, S. Altuwaijri. 2003 Fig. 2)

Mouse Monoclonal
Species Human, Primate
Applications WB, IHC, IHC-P

12 Publications

Mouse Monoclonal
Species Human
Applications WB, IHC, IP

     2 Reviews

1 Publication

Mouse Monoclonal
Species Human
Applications WB

2 Publications
Functional (Inhibition): NFkB p105/p50 Inhibitor Peptide Set [NBP2-29323] - TLR5/NF-kB/SEAPorter HEK 293 (NBP2-26277) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were preincubated with different concentrations (0, 1, 5, 10, 25 and 50 uM) of Inhibitory Peptide (NBP2-29323) and Control Peptide (NBP2-29334) for 1 h. Cells were then stimulated with 1 ng/ml Flagellin (NBP2-25289) for 24 h. Secreted alkaline phosphatase (SEAP) was analyzed using SEAPorter Assay Kit (NBP2-25285). *p < 0.05 versus control peptide at the corresponding concentrations (Mann-Whitney U test).

Species Human, Mouse, Rat
Applications Func-Inh

9 Publications
Western Blot: AKR1B1 Antibody [NBP1-89146] - Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11<br/>Lane 2: Human cell line RT-4<br/>Lane 3: Human cell line U-251MG spImmunocytochemistry/Immunofluorescence: AKR1B1 Antibody [NBP1-89146] - Staining of human cell line A-431 shows positivity in nucleus but not nucleoli & cytoplasm.

Rabbit Polyclonal
Species Human
Applications WB, ICC/IF, IHC